<DOC>
	<DOCNO>NCT00953043</DOCNO>
	<brief_summary>This study do evaluate effect lubiprostone , drug approve used constipation , pattern contraction colon colon 's sensitivity distension .</brief_summary>
	<brief_title>Lubiprostone , Colonic Motility Sensation</brief_title>
	<detailed_description>This trial healthy adult compare effect oral lubiprostone , 24 microgram per day placebo three day , sensation contraction colon use validate method . On day 1 2 , participant take study medication breakfast record time . On day 2 start 4:00 pm , participant start polyethylene glycol-based bowel preparation cleanse colon . After overnight bowl preparation , participant report fast study center 7:00 day 3 . Colonic sensorimotor function assess endoscopically place barostat-manometric assembly . After 30 minute rest follow tube placement , fast colonic tone , colonic compliance colonic sensation test . The last dose medication ingest 1 hour later colonic function , well colonic response standardize meal 1,000-kilocalorie chocolate milkshake assess . The participant able leave study center afternoon , meal ingest ( desire ) . Details colonic tube placement : A flexible sigmoidoscopy perform evaluate left side colon place Teflon-coated guide wire beyond splenic flexure . The colon deflate sigmoidoscope remove barostat catheter ( construct Mayo Clinic , Rochester , MN ) six manometric point sensor polyethylene balloon introduce colon guide wire . The barostat catheter position mid-descending upper sigmoid colon aid fluoroscopy . The final position barostatically control balloon confirm fluoroscopy . After colonic tube placement , participant rest 30 min . The catheter connect rigid piston barostat machine . After transient inflation barostat bag volume 75 ml ensure unfolded , deflate . Thereafter , inflate 2 mm Hg increment baseline operating pressure , define 2 mm Hg minimal distension pressure respiratory excursion clearly record barostat tracing .</detailed_description>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Inclusion criterion : Healthy subject Body mass index ( BMI ) : 18 32 . Negative pregnancy test woman childbearing potential . Absence gastrointestinal symptom ( abridge Bowel Disease Questionnaire ) . Signed informed consent . Exclusion criterion : Subjects body mass index ( BMI ) less 18 32 . Structural metabolic diseases/conditions affect gastrointestinal ( GI ) system , functional gastrointestinal disorder . For screen , Bowel Disease Questionnaire use exclude subject irritable bowel syndrome . Use drug agent within past 2 week alter GI transit include laxative , magnesium aluminumcontaining antacid , prokinetics , erythromycin , narcotic , anticholinergic , tricyclic antidepressant , SSRI new antidepressant . NOTE : Low stable dos thyroid replacement , estrogen replacement , low dose aspirin cardioprotection , birth control pills depot injection permissible . Use drug agent within 2 week prior screen may add drowsiness central nervous system ( CNS ) depression barbiturate , benzodiazepine , ethanol , lithium , opioids , buspirone , antihistamine , muscle relaxant , CNS depressant . Female subject pregnant breast feeding . Females must either surgically sterilize , postmenopausal ( &gt; 12 month since last menses ) , childbearing potential , use reliable method contraception determine physician ( singlebarrier method alone rhythm method acceptable ) . Clinical evidence ( include physical exam ECG ) significant cardiovascular , respiratory , renal , hepatic , gastrointestinal , hematological , neurological , psychiatric , disease interfere objective study . Any candidate participant disorder mention referred general physician . The Hospital Anxiety Depression Scale ( HADS ) use exclude subject significant affective disorder , well determine anxiety depression score start study . Any candidate participant disorder mention referred general physician . Symptoms significant clinical illness two week prior screen . Participation another clinical study within 30 day prior screen . Subjects consider investigator alcoholic remission know substance abuser .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>lubiprostone</keyword>
	<keyword>colon</keyword>
	<keyword>motility</keyword>
	<keyword>sensation</keyword>
</DOC>